Lifestyle And Testicular Dysfunction: A Brief Update UroToday.com - A variety of testicular pathologies to include testicular cancer, cryptorchidism and defective spermatogenesis have been increasing. While genetic factors play a role, growing evidence suggests that the testicle is damaged by environment and lifestyle-related factors either prenatally or at puberty.
Source: www.medicalnewstoday.comThe Case For Prostate-Specific Antigen Screening Starting At Age 40 UroToday.com - Dr. Robert Nadler, of Northwestern University, wrote an excellent editorial in a recent issue of Cancer regarding the commencement of prostate cancer (CaP) screening at age 40. The National Comprehensive Cancer Care Network (NCCN) recommends an initial PSA at age 40 for men of all races. The frequency of subsequent PSA tests would depend on the initial level.
Source: www.medicalnewstoday.comRevenue Recognition Principles Negatively Impact The Biotechnology Industry, New Study Confirms Current revenue recognition accounting principles continue to place unnecessary challenges on small and medium-sized biotechnology companies who enter into collaborative arrangements, according to an independent study released today by the Biotechnology Industry Organization (BIO). The study, entitled "Revenue Recognition for Collaborative Arrangements in the Biotechnology Industry, was conducted by Glass, Lewis, & Co., LLC, a leading research and professional services firm.
Source: www.medicalnewstoday.comPartnership To Develop Next Generation Of HIV Vaccines Elevation Biotech, a start-up biotechnology company funded by LIFElab, an agency of the South African Department of Science and Technology, and the International AIDS Vaccine Initiative (IAVI), the world's only global non-profit organization dedicated solely to AIDS vaccine development, have partnered to develop the next generation of AIDS vaccine candidates. "An AIDS vaccine remains our best hope for ending AIDS.
Source: www.medicalnewstoday.comWisconsin's Biotechnology & Medical Device Association Applauds Historic Genomic Research Initiative The following is a statement by Jim Leonhart, executive director of the Wisconsin Biotechnology & Medical Device Association, regarding this morning's announcement by Gov. Jim Doyle of the Wisconsin Genomics Initiative. The initiative is a public-private partnership that includes Marshfield Clinic, the Medical College of Wisconsin, the University of Wisconsin School of
Medicine and Public
Health, and UW-Milwaukee. "Today's historic announcement by Gov.
Source: www.medicalnewstoday.comDrug Companies Plan To Invest In HIV/AIDS Drug Development, Improve Access, U.N. Secretary-General Says United Nations Secretary-General Ban Ki-moon on Thursday said that many large pharmaceutical companies -- including Abbott Labs, Boehringer Ingelheim, GlaxoSmithKline and Pfizer -- plan to increase their efforts to develop HIV/AIDS
drugs and diagnostics for impoverished regions, Reuters reports.
Source: www.medicalnewstoday.comSexually Transmissible Infections And Prostate Cancer Risk UroToday.com - Circulating antibodies against infectious agents and self-reported history of syphilis and gonorrhea represent an individual's cumulative lifetime exposure or past infections, and thus are particularly suited for risk evaluation of cancer with a long latent disease process.
Source: www.medicalnewstoday.comLeading Drug Database To Be Housed At U-M The University of Michigan received $5 million from the National Institutes of
Health to develop the world's leading resource of high-quality experimental data sets of drug-making compounds that will ultimately take computer-aided drug design to a new level. The resource will house the data needed to improve computer programs that can predict the effectiveness of potential new
drugs, said Heather Carlson, associate professor in the U-M College of Pharmacy and Medicinal Chemistry.
Source: www.medicalnewstoday.com
# posted by Network @ 1:00 PM
